Ether

Ether

SCHEMBL1679520

CCOCC.c1ccc(P(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.60
TDP1 Q9NUW8 1/20 0.60
ESR1 P03372 3/20 0.46
ESR2 Q92731 3/20 0.46
KDM4E B2RXH2 3/20 0.37
GAA P10253 1/20 0.37
LTA4H P09960 1/20 0.37
TP53 P04637 1/20 0.36
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TSHR P16473 2/20 0.35
RELA Q04206 1/20 0.33
POLB P06746 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
KCNN4 O15554 1/20 0.33
DRD1 P21728 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ether SCHEMBL17061168 0.98 CYP3A4 (0.57) CYP3A4TDP1ESR1ESR2KDM4E
SCHEMBL6260735 0.87 TDP1 (0.50) CYP3A4TDP1ESR1ESR2KDM4E
SCHEMBL29024165 0.85 CYP3A4 (0.60) CYP3A4TDP1ESR1ESR2KDM4E
SCHEMBL27745065 0.85 CYP3A4 (0.48) CYP3A4TDP1ESR1ESR2KDM4E
Propane SCHEMBL27796760 0.84 CYP3A4 (0.75) CYP3A4TDP1ESR1ESR2KDM4E
Propane SCHEMBL28233649 0.84 CYP3A4 (0.75) CYP3A4TDP1ESR1ESR2KDM4E
Ether SCHEMBL1131751 0.83 CYP3A4 (0.41) CYP3A4TDP1ESR1ESR2KDM4E
Butane SCHEMBL27989459 0.81 CYP3A4 (0.71) CYP3A4TDP1ESR1ESR2KDM4E
Butane SCHEMBL28244852 0.81 CYP3A4 (0.71) CYP3A4TDP1ESR1ESR2KDM4E
SCHEMBL8845876 0.81 CYP3A4 (0.55) CYP3A4TDP1ESR1ESR2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115124570-B Preparation method of C3 phosphine salt 万华化学集团股份有限公司 2024-06-25 CN disclosed
CN-104370793-B Pyroles marine alkaloids Neolamellarin A analogs and its preparation method and application 中国海洋大学 2017-10-17 CN disclosed
EP-2486070-B1 INCREASE IN THE TOUGHNESS OF A MATERIAL ACHIEVED BY MEANS OF A CURABLE COMPOSITION INCLUDING AT LEAST ONE VINYL ESTER MONOMER AIRBUS SAFRAN LAUNCHERS SAS (FR) 2017-05-17 EP disclosed
US-8618186-B2 Increase in the toughness of a material obtained from a curable composition comprising at least one vinyl ester monomer ASTRIUM SAS (FR) 2013-12-31 US disclosed
US-20120277383-A1 INCREASE IN THE TOUGHNESS OF A MATERIAL OBTAINED FROM A CURABLE COMPOSITION COMPRISING AT LEAST ONE VINYL ESTER MONOMER ASTRIUM SAS (FR) 2012-11-01 US disclosed
EP-2486070-A1 INCREASE IN THE TOUGHNESS OF A MATERIAL ACHIEVED BY MEANS OF A CURABLE COMPOSITION INCLUDING AT LEAST ONE VINYL ESTER MONOMER Astrium SAS (FR) 2012-08-15 EP disclosed
WO-2011042554-A1 INCREASE IN THE TOUGHNESS OF A MATERIAL ACHIEVED BY MEANS OF A CURABLE COMPOSITION INCLUDING AT LEAST ONE VINYL ESTER MONOMER ASTRIUM SAS (FR) 2011-04-14 WO disclosed
CN-101237892-A Method for conjugating molecules containing an aminothiol to a carrier AMGEN INC (US) 2008-08-06 CN disclosed
EP-1848463-A2 METHOD OF CONJUGATING AMINOTHIOL CONTAINING MOLECULES TO VEHICLES Amgen Inc. (US) 2007-10-31 EP disclosed
US-20060199812-A1 Method of conjugating aminothiol containing molecules to vehicles AMGEN INC. 2006-09-07 US disclosed
WO-2006079099-A2 METHOD OF CONJUGATING AMINOTHIOL CONTAINING MOLECULES TO A POLYMER AMGEN INC. (US) 2006-07-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060199812-A1 Method of conjugating aminothiol containing molecules to vehicles SLC7A1, QPCT, SLC7A5 CYP3A4 3682/4885TDP1 1848/4885ESR1 3904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.